Europe Dog Dewormers Market Size, Growth, Trends | Report 2023-2032
The Europe dog dewormers market was surpassed at USD 386.27 million in 2022 and is expected to hit around USD 1,067.50 million by 2032, growing at a CAGR of 10.7% from 2023 to 2032.
Key Pointers
Increasing healthcare expenditure on dogs and the rising adoption of e-commerce websites to order supplies for pets are some of the major factors driving the market growth. Furthermore, the high canine population and its ownership are also expected to fuel market growth. According to FEDIAF’s 2022 report, the Europe region had nearly 312 million pets, with 92.9 million dogs as of 2021.
The growing dog population is expected to boost the need for veterinary healthcare services and increase the overall expenditure on them. In October 2020, N26 GmbH, an insurance serving company in Germany, stated that around USD 16 to USD 53 (i.e. EUR 15-50) per month is invested in dog insurance, based on the type of animal breed. As per the same source, USD 52.8 to USD 63.36 is spent on routine veterinary care per visit.
Similarly, the People’s Dispensary for Sick Animals PDSA 2022, reported that dog owners in the U.K. spend around USD 6,122 to USD 14,937, over their lifetime. Furthermore, according to a report published by EAE Business School in July 2017, the average annual spending on dogs in Spain was around USD 121.95 (EUR 130) per household. Therefore, the willingness of people to spend more on their dog’s healthcare is propelling the industry’s growth.
Market players are investing more time and money in R&D activities and developing new as well as advancing existing products for better animal health outcomes. In 2021, Dechra Pharmaceuticals reported their recent acquisition of Mirataz, Osumia and 15% of Medical Ethics has strengthened their pipeline activities.
Norbrook launched five R&D projects in the last 12 months, with plans to develop 10 more products in the next 2 years. Elanco, in its investor presentations, reported a shift in purchasing behavior of veterinarians, farmers, as well as pet parents to online channels. The company has thus identified continuous digital ecosystem enhancement as a key growth driver.
Europe Dog Dewormers Market Segmentations and Key Players:
| By Distribution Channel | Key Players |
|
Veterinary Clinics Retail/Pet Stores E-Commerce |
Merck & Co., Inc. Boehringer Ingelheim International GmbH Virbac Elanco Ceva Zoetis PetIQ, LLC Sava Healthcare Limited |
Chapter 1. Introduction
1.1.Research Objective
1.2.Scope of the Study
1.3.Definition
Chapter 2. Research Methodology
2.1.Research Approach
2.2.Data Sources
2.3.Assumptions & Limitations
Chapter 3. Executive Summary
3.1.Market Snapshot
Chapter 4. Market Variables and Scope
4.1.Introduction
4.2.Market Classification and Scope
4.3.Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5.COVID 19 Impact on Europe Dog Dewormers Market
5.1. COVID-19 Landscape: Europe Dog Dewormers Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4.Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1.Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2.Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1.List of Suppliers
7.1.3.2.List of Buyers
Chapter 8. Europe Dog Dewormers Market, By Distribution Channel
8.1.Europe Dog Dewormers Market, by Distribution Channel Type, 2023-2032
8.1.1. Veterinary Clinics
8.1.1.1.Market Revenue and Forecast (2019-2032)
8.1.2. Retail/Pet Stores
8.1.2.1.Market Revenue and Forecast (2019-2032)
8.1.3. E-Commerce
8.1.3.1.Market Revenue and Forecast (2019-2032)
Chapter 9. Europe Dog Dewormers Market, Regional Estimates and Trend Forecast
9.1. Europe
9.1.1. Market Revenue and Forecast, by Distribution Channel (2019-2032)
Chapter 10.Company Profiles
10.1. Merck & Co., Inc.
10.1.1.Company Overview
10.1.2.Product Offerings
10.1.3.Financial Performance
10.1.4.Recent Initiatives
10.2. Boehringer Ingelheim International GmbH
10.2.1.Company Overview
10.2.2.Product Offerings
10.2.3.Financial Performance
10.2.4.Recent Initiatives
10.3. Virbac
10.3.1.Company Overview
10.3.2.Product Offerings
10.3.3.Financial Performance
10.3.4.Recent Initiatives
10.4. Elanco
10.4.1.Company Overview
10.4.2.Product Offerings
10.4.3.Financial Performance
10.4.4.Recent Initiatives
10.5. Ceva
10.5.1.Company Overview
10.5.2.Product Offerings
10.5.3.Financial Performance
10.5.4.Recent Initiatives
10.6. Zoetis
10.6.1.Company Overview
10.6.2.Product Offerings
10.6.3.Financial Performance
10.6.4.Recent Initiatives
10.7. PetIQ, LLC
10.7.1.Company Overview
10.7.2.Product Offerings
10.7.3.Financial Performance
10.7.4.Recent Initiatives
10.8. Sava Healthcare Limited
10.8.1.Company Overview
10.8.2.Product Offerings
10.8.3.Financial Performance
10.8.4.Recent Initiatives
Chapter 11.Research Methodology
11.1.Primary Research
11.2.Secondary Research
11.3.Assumptions
Chapter 12.Appendix
12.1. About Us
12.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers